Glucose priming may improve tumor targeting for chemotherapy nanocarriers
Chemotherapy selectivity is limited by systemic toxicity. pH‑sensitive nanocarriers exploit tumor acidity as a release trigger but respond passively to a modest, heterogeneous gradient.
Read original article on The Medical News →Related news
-
Wearable pressure sensor uses cold-spray adhesion method for enhanced health monitoring
United Kingdom
-
Childhood measles vaccination rates fall worldwide post-COVID-19
United Kingdom
-
Experimental treatment selectively reduces harmful protein in lab models of rare inherited brain disorder
United Kingdom
-
Existing cancer drug reduces blood vessel malformations in the brain
United Kingdom
-
Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
United Kingdom
-
'Digital twins' of immune system in pregnancy identify drugs to prevent early labor
United Kingdom
-
Nearly half of on-duty firefighter deaths are heart-related
United Kingdom
-
Modifiable psychosocial factors linked to depression among US cancer survivors
United Kingdom